Could this pill beat long COVID fatigue? new trial launches
Symptom relief
Recruiting now
This study tests whether the drug sonlicromanol can reduce fatigue in people with post-COVID condition who also experience post-exertional malaise (PEM). About 80 adults with mild initial COVID-19 will receive either the drug or a placebo for several weeks. The main goal is to se…
Phase: PHASE2 • Sponsor: Michele van Vugt • Aim: Symptom relief
Last updated May 17, 2026 22:02 UTC